| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Federico Frau, Chiara Cerami, Alessandra Dodich, Marta Bosia, Valentina Bambin. Weighing the role of social cognition and executive functioning in pragmatics in the schizophrenia spectrum: A systematic review and meta-analysis. Brain and language. vol 252. 2024-04-09. PMID:38593743. |
this systematic review and meta-analysis aimed to investigate the neurocognitive correlates of pragmatic disorders in schizophrenia and determine the weight of social cognition and executive functioning on such disorders. |
2024-04-09 |
2024-04-12 |
Not clear |
| Temi Toba-Oluboka, Kara Dempste. A Narrative Review Exploring Attention Deficit/Hyperactivity Disorder in Patients with Early Psychosis. Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539580. |
while both attention deficit hyperactivity disorder (adhd) and schizophrenia are considered to have neurodevelopmental origins with associated impairments in executive functioning, there is a paucity of clinical guidelines pertaining specifically to this comorbidity. |
2024-03-28 |
2024-03-30 |
Not clear |
| Giulia Spoto, Gabriella Di Rosa, Antonio Gennaro Nicoter. The Impact of Genetics on Cognition: Insights into Cognitive Disorders and Single Nucleotide Polymorphisms. Journal of personalized medicine. vol 14. issue 2. 2024-02-23. PMID:38392589. |
focusing on neurotransmitter regulation within the prefrontal cortex's dopaminergic circuits, this study emphasizes the role of genes like comt, prodh, and drd in shaping executive functions and influencing conditions such as adhd and schizophrenia. |
2024-02-23 |
2024-02-25 |
Not clear |
| Shuwei Yi, Qing Wang, Wenjie Wang, Chaokun Hong, Zhibin Re. Efficacy of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms and cognitive functioning in schizophrenia: An umbrella review of systematic reviews and meta-analyses. Psychiatry research. vol 333. 2024-01-17. PMID:38232567. |
most reviews indicate that rtms has an effect on negative symptoms, executive function, working memory, and language function in patients with schizophrenia. |
2024-01-17 |
2024-01-20 |
Not clear |
| Nuria Pérez-Romero, Christian Campos-Jara, Caterina Pesce, Sergio Araya Sierralta, Enrique Cerda-Vega, Rodrigo Ramirez-Campillo, Rodrigo Campos-Jara, Cristian Martínez-Salazar, Cristián Arellano-Roco, Falonn Contreras-Osori. Effects of physical exercise on executive functions of individuals with schizophrenia spectrum disorders: Protocol for a systematic review and meta-analysis. PloS one. vol 19. issue 1. 2024-01-04. PMID:38165903. |
however, there are only few systematic reviews of exercise effects in schizophrenia including cognitive outcomes, and no meta-analytical syntheses of effects on "cool" and "hot" executive functions. |
2024-01-04 |
2024-01-06 |
Not clear |
| Nicholas Theis, Jyotika Bahuguna, Jonathan Rubin, Brendan Muldoon, Konasale Prasa. Energy in functional brain states correlates with cognition in adolescent schizophrenia and healthy persons. bioRxiv : the preprint server for biology. 2023-11-24. PMID:37987003. |
here, we apply the mem framework to task functional mri data collected on 23 adolescent onset schizophrenia (aos) since aos is a more severe form of schizophrenia with more severe cognitive impairments and poorer outcome, in comparison with 53 healthy control subjects while performing the penn conditional exclusion test (pcet), which measures abstraction and mental flexibility, aspects of executive function that have repeatedly been shown to be impaired in aos. |
2023-11-24 |
2023-11-28 |
human |
| Alejandra Mondragón-Maya, Yvonne Flores-Medina, Daniel González-Sánchez, Elizabeth Hernández-Echeagara. Similarities in cognitive impairment between recent- onset and chronic schizophrenia patients: a consideration for the neurodevelopmental hypothesis. Actas espanolas de psiquiatria. vol 51. issue 4. 2023-10-11. PMID:37817737. |
impairment in attention, memory, processing speed and executive functions have been described in patients with schizophrenia. |
2023-10-11 |
2023-10-15 |
Not clear |
| David H Adamowicz, Tsung-Chin Wu, Rebecca Daly, Michael R Irwin, Dilip V Jeste, Xin M Tu, Lisa T Eyler, Ellen E Le. Executive functioning trajectories and their prospective association with inflammatory biomarkers in schizophrenia and non-psychiatric comparison participants. Progress in neuro-psychopharmacology & biological psychiatry. 2023-09-24. PMID:37742747. |
executive functioning trajectories and their prospective association with inflammatory biomarkers in schizophrenia and non-psychiatric comparison participants. |
2023-09-24 |
2023-10-07 |
human |
| Muhammad S Abbas, Sondos T Nassar, Tasniem Tasha, Anjali Desai, Anjana Bajgain, Asna Ali, Chandrani Dutta, Khadija Pasha, Salomi Paul, Sathish Venugopa. Exercise as an Adjuvant Treatment of Schizophrenia: A Review. Cureus. vol 15. issue 7. 2023-08-21. PMID:37602139. |
schizophrenia is a chronic debilitating condition associated with impaired social functioning, memory, and executive functioning. |
2023-08-21 |
2023-09-07 |
Not clear |
| b' Zehra G\\xc3\\xbcnay Ya\\xc4\\x9fci, Mehmet Hamid Bozta\\xc5\\x9. Examination of the Relationship Between the Theory of Mind, Neurocognitive Functions and Thought-Language Features in the Schizophrenia and Bipolar Affective Disorder I Groups. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 34. issue 2. 2023-06-26. PMID:37357893.' |
in this study, it was aimed to examine the relationship of tom with face-emotion recognition, executive functions and thought disorders in the schizophrenia (sc) and bipolar affective disorder i (bad i) groups. |
2023-06-26 |
2023-08-14 |
Not clear |
| Yajing Si, Congcong Liu, Yanna Kou, Zhao Dong, Jiajia Zhang, Juan Wang, Chengbiao Lu, Yanyan Luo, Tianjun Ni, Yunhong Du, Hongxing Zhan. Antipsychotics-induced improvement of cool executive function in individuals living with schizophrenia. Frontiers in psychiatry. vol 14. 2023-05-15. PMID:37181875. |
antipsychotics-induced improvement of cool executive function in individuals living with schizophrenia. |
2023-05-15 |
2023-08-14 |
Not clear |
| Yajing Si, Congcong Liu, Yanna Kou, Zhao Dong, Jiajia Zhang, Juan Wang, Chengbiao Lu, Yanyan Luo, Tianjun Ni, Yunhong Du, Hongxing Zhan. Antipsychotics-induced improvement of cool executive function in individuals living with schizophrenia. Frontiers in psychiatry. vol 14. 2023-05-15. PMID:37181875. |
together, the findings deepened our understanding of cool executive function in individuals living with schizophrenia and might provide physiological information to reliably predict the clinical efficacy of schizophrenia after atypical antipsychotic treatment. |
2023-05-15 |
2023-08-14 |
Not clear |
| Gricel Orellana, Andrea Slachevsky, Fernando Henrique. Dysexecutive Behavior in First-Episode Schizophrenia. Clinical schizophrenia & related psychoses. vol 16. issue Suppl 3. 2023-04-27. PMID:37101576. |
this study assesses and correlates executive function (ef) deficits and dysexecutive behavior (db) in first-episode schizophrenia (fes) patients and healthy participants. |
2023-04-27 |
2023-08-14 |
human |
| Feifei Xu, Zhenping Xia. Study investigating executive function in schizophrenia patients and their unaffected siblings. PloS one. vol 18. issue 4. 2023-04-26. PMID:37099556. |
study investigating executive function in schizophrenia patients and their unaffected siblings. |
2023-04-26 |
2023-08-14 |
Not clear |
| Feifei Xu, Zhenping Xia. Study investigating executive function in schizophrenia patients and their unaffected siblings. PloS one. vol 18. issue 4. 2023-04-26. PMID:37099556. |
schizophrenia (scz) is characterized by widespread cognitive impairments, such as executive functions. |
2023-04-26 |
2023-08-14 |
Not clear |
| Ipek Özönder Ünal, Tonguc D Berko. Investigation of Apraxia in Patients with Schizophrenia and Bipolar Disorder Type I. Psychiatria Danubina. vol 35. issue 1. 2023-04-15. PMID:37060592. |
almost 50% of patients with schizophrenia experience problems in their praxia performance, whereas executive function losses can be seen in patients with bipolar disorder. |
2023-04-15 |
2023-08-14 |
Not clear |
| Emre Bora, Berna Yalincetin, Berna Binnur Akdede, Köksal Alpteki. Deficits in Analytic and Common-Sense Reasoning in Schizophrenia. The Journal of nervous and mental disease. vol 211. issue 5. 2023-04-11. PMID:37040138. |
executive functions and verbal memory were also significantly associated with analytic reasoning in schizophrenia. |
2023-04-11 |
2023-08-14 |
human |
| Yi Nam Suen, Sze Wing Tiffanie Pang, Charlton Cheung, Ting Yat Wong, Lai Ming Christy Hui, Ho Ming Edwin Lee, Wing Chung Chang, Yu Hai Eric Chen, Sherry Kit Wa Cha. Impact of early negative symptom patterns on the long-term outcomes of patients with first-episode schizophrenia-spectrum disorders: A 12-year follow up study. Psychiatry research. vol 323. 2023-03-29. PMID:36989910. |
our findings support the notion that severity of early ns influences the prognosis of schizophrenia and the closer examination revealed that the severity and variability of early ns are differentially associated with long-term clinical symptoms, executive function, and functional outcomes via distinct pathways. |
2023-03-29 |
2023-08-14 |
Not clear |
| Nabi Zorlu, Adem Bayrakçı, Merve Karakılıç, Andrew Zalesky, Caio Seguin, Ye Tian, Funda Gülyüksel, Berna Yalınçetin, Elif Oral, Fazıl Gelal, Emre Bor. Abnormal Structural Network Communication Reflects Cognitive Deficits in Schizophrenia. Brain topography. 2023-03-27. PMID:36971857. |
among different measures of communication efficiency, only navigation efficiency was associated with global cognitive impairment across multiple cognitive domains including verbal learning, processing speed, executive functions and working memory, in individuals with schizophrenia. |
2023-03-27 |
2023-08-14 |
Not clear |
| Hema Tharoor, Sindhu Maran, Antra K Chandan, Manikandan Pari, Shruti Rao, Jothilakshmi Duraira. Cognitive and negative symptoms in schizophrenia with L-Carnosine adjuvant therapy - A randomized double-blind placebo-controlled study. Pharmacology research & perspectives. vol 11. issue 2. 2023-03-22. PMID:36946070. |
l-carnosine dosing of 800 mg may be a promising agent to enhance executive functions in schizophrenia. |
2023-03-22 |
2023-08-14 |
Not clear |